Paper39609558
Antibiotic-mediated selection of randomly mutagenized and cytokine-expressing oncolytic viruses.
Rezaei R and 33 others. Nat Biomed Eng, 2025. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Antibiotic-mediated selection of randomly mutagenized and cytokine-expressing oncolytic viruses. Papers, record 39609558. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39609558
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antibiotic-mediated selection of randomly mutagenized and cytokine-expressing oncolytic viruses.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Oncolytic Viruses | Major topic |
| Cytokines | Major topic |
| Anti-Bacterial Agents | Major topic |
| Humans | |
| Transgenes | |
| Herpesvirus 1, Human | |
| Oncolytic Virotherapy | |
| Vaccinia virus | |
| Animals | |
| Cell Line, Tumor | |
| Virus Replication | |
| Mutagenesis, Insertional | |
| Mutagenesis |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 448323 | Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (Skin Research Training Centre) | PubMed |
Source PubMed
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17299401 | History of oncolytic viruses: genesis to genetic engineering. | Mol Ther | 2007 | https://conductscience.org/library/papers/17299401 | PubMed |
| 2 | 32071927 | Oncolytic Viruses and the Immune System: The Dynamic Duo. | Mol Ther Methods Clin Dev | 2020 | https://conductscience.org/library/papers/32071927 | PubMed |
| 3 | 38283361 | Oncolytic vaccinia virus and cancer immunotherapy. | Front Immunol | 2023 | https://conductscience.org/library/papers/38283361 | PubMed |
| 4 | 32297534 | Engineering vaccinia virus as an immunotherapeutic battleship to overcome tumor heterogeneity. | Expert Opin Biol Ther | 2020 | https://conductscience.org/library/papers/32297534 | PubMed |
| 5 | 29576283 | Armed oncolytic viruses: A kick-start for anti-tumor immunity. | Cytokine Growth Factor Rev | 2018 | https://conductscience.org/library/papers/29576283 | PubMed |
| 6 | 37041165 | Oncolytic virotherapy: basic principles, recent advances and future directions. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37041165 | PubMed |
| 7 | 19169955 | Diplomatic immunity: turning a foe into an ally. | Curr Opin Mol Ther | 2009 | https://conductscience.org/library/papers/19169955 | PubMed |
| 8 | 2994215 | Genetic engineering of novel genomes of large DNA viruses. | Science | 1985 | https://conductscience.org/library/papers/2994215 | PubMed |
| 9 | 35584888 | The Life Cycle of the Vaccinia Virus Genome. | Annu Rev Virol | 2022 | https://conductscience.org/library/papers/35584888 | PubMed |
| 10 | 26462293 | Designing Herpes Viruses as Oncolytics. | Mol Ther Oncolytics | 2015 | https://conductscience.org/library/papers/26462293 | PubMed |
| 11 | 7607536 | Selection of recombinant vaccinia viruses on the basis of plaque formation. | Gene | 1995 | https://conductscience.org/library/papers/7607536 | PubMed |
| 12 | 33144673 | Rapid poxvirus engineering using CRISPR/Cas9 as a selection tool. | Commun Biol | 2020 | https://conductscience.org/library/papers/33144673 | PubMed |
| 13 | 31617178 | CRISPR/Cas9-Based Genome Editing of HSV. | Methods Mol Biol | 2020 | https://conductscience.org/library/papers/31617178 | PubMed |
| 14 | 36713447 | CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX. | Front Immunol | 2022 | https://conductscience.org/library/papers/36713447 | PubMed |
| 15 | 34200544 | Methods for the Manipulation of Herpesvirus Genome and the Application to Marek's Disease Virus Research. | Microorganisms | 2021 | https://conductscience.org/library/papers/34200544 | PubMed |
| 16 | 11435572 | Effects of DNA structure and homology length on vaccinia virus recombination. | J Virol | 2001 | https://conductscience.org/library/papers/11435572 | PubMed |
| 17 | 23209131 | Tinkering with translation: protein synthesis in virus-infected cells. | Cold Spring Harb Perspect Biol | 2013 | https://conductscience.org/library/papers/23209131 | PubMed |
| 18 | 12209136 | Viruses and interferon: a fight for supremacy. | Nat Rev Immunol | 2002 | https://conductscience.org/library/papers/12209136 | PubMed |
| 19 | 32455727 | Vaccinia Virus as a Master of Host Shutoff Induction: Targeting Processes of the Central Dogma and Beyond. | Pathogens | 2020 | https://conductscience.org/library/papers/32455727 | PubMed |
| 20 | 34051235 | Choice of selectable marker affects recombinant protein expression in cells and exosomes. | J Biol Chem | 2021 | https://conductscience.org/library/papers/34051235 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42039816 | Oncolytic viruses in lung cancer: mechanisms of action and research progress. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42039816 | PubMed |
| 41917920 | Bridging mechanism and clinic: unlocking the full potential of oncolytic virus-based immunotherapy. | Mol Cancer | 2026 | https://conductscience.org/library/papers/41917920 | PubMed |
| 41593888 | Application of artificial intelligence in head and neck squamous cell carcinoma. | Ann Med | 2026 | https://conductscience.org/library/papers/41593888 | PubMed |
| 41291902 | TIM-3 blockade reverses oncolytic vaccinia virus-induced DCs inactivation and T cells exhaustion to improve antitumor immunity and therapeutic efficacy. | J Exp Clin Cancer Res | 2025 | https://conductscience.org/library/papers/41291902 | PubMed |
| 40723208 | Vaccinia Virus-A Swiss Army Knife Against Cancer. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40723208 | PubMed |
| 40143547 | Oncolytic viruses as cancer therapeutics: From mechanistic insights to clinical translation. | Mol Ther | 2025 | https://conductscience.org/library/papers/40143547 | PubMed |
| 39609557 | Antibiotic-driven boosting of oncolytic virotherapy. | Nat Biomed Eng | 2025 | https://conductscience.org/library/papers/39609557 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39609558
GET https://conductscience.org/api/papers/v1/39609558/authors?page=2